| Product Code: ETC067004 | Publication Date: Jul 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Thailand Non-Oncology Precision Medicine Market was estimated at USD 167 Million in 2025 and is projected to reach USD 191 Million by 2032, growing at a CAGR of 1.9% from 2026 to 2032. This growth is significantly driven by the increasing recognition of the importance of personalized healthcare solutions tailored to individual genetic and lifestyle factors, specifically in chronic disease management. Additionally, advancements in technology and genomic research are creating unprecedented opportunities for innovative treatment methodologies that address specific health needs across diverse non-oncology specialties.
This graph highlights how the Thailand Non-Oncology Precision Medicine Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.5% | Increasing adoption of advanced technologies |
| 2022 | 2.3% | Increasing adoption of advanced technologies |
| 2023 | 3.0% | Expansion of manufacturing activities |
| 2024 | 3.0% | Growing urbanization and commercial development |
| 2025 | 3.0% | Expansion of manufacturing activities |
| 2026 | 3.1% | Expansion of manufacturing activities |
| 2027 | 2.4% | Expansion of transportation and logistics networks |
| 2028 | 2.4% | Increasing adoption of advanced technologies |
| 2029 | 2.8% | Increasing industrial infrastructure investments |
| 2030 | 2.8% | Increasing adoption of advanced technologies |
| 2031 | 3.2% | Increasing industrial infrastructure investments |
| 2032 | 2.9% | Increasing adoption of advanced technologies |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
In Thailand, there is a rising demand for non-oncology precision medicine, particularly in cardiology and neurology, as more healthcare professionals recognize the need for targeted therapies. This shift is underpinned by a growing patient population suffering from chronic conditions that benefit significantly from personalized treatment plans.
Moreover, the Thai healthcare system is gradually integrating digital health technologies, including biomarker testing and genetic profiling, which are essential components of precision medicine. As these technologies become more accessible, they are expected to enhance the quality of care and improve health outcomes for patients across various non-oncology fields.
Despite its promising potential, the Thailand non-oncology precision medicine market faces certain constraints. Data privacy concerns pose significant challenges, as maintaining patient confidentiality while leveraging genetic and health data for personalized treatments is a complex task. Additionally, high costs associated with precision medicine technologies can inhibit accessibility, particularly in resource-limited settings. Regulatory hurdles related to these advanced therapies further complicate the landscape, necessitating comprehensive guidelines and frameworks to facilitate market growth.
Current trends indicate a growing emphasis on collaboration between technology firms and healthcare providers to develop innovative solutions that enhance precision medicine delivery. Furthermore, there is an increasing interest in telemedicine, which allows healthcare providers to utilize precision medicine techniques remotely, thereby improving access for patients in rural and underserved areas. Another significant trend is the rising incorporation of artificial intelligence and machine learning in diagnostics and treatment planning, which promises to increase the accuracy and efficiency of precision medicine interventions.
The landscape for non-oncology precision medicine in Thailand is ripe with opportunities for growth and investment. As public awareness of personalized healthcare increases, there is a unique chance for companies to develop and market precision medicine solutions tailored specifically to the Thai population's needs. Investment in R&D for biomarker discovery and genetic testing presents lucrative possibilities. Additionally, partnerships with local healthcare institutions could facilitate more rapid adoption of these innovative therapies, paving the way for significant advancements in patient care.
The Thai government has shown increasing support for the integration of precision medicine into the healthcare system through various initiatives aimed at improving health outcomes. Public spending on healthcare innovation is on the rise, with a focus on developing genomic research capabilities and enhancing healthcare infrastructure. Programs promoting collaboration between government, industry, and academic institutions are fostering an environment conducive to the growth of precision medicine, ensuring that it becomes an integral part of Thailand’s healthcare strategy.
Looking ahead, the Thailand non-oncology precision medicine market is poised for substantial growth between 2026 and 2032. As healthcare systems adapt to prioritize personalized approaches, we can anticipate greater investments in technology and infrastructure supporting precision medicine applications. The increasing prevalence of chronic diseases, combined with the growing acceptance of genomic testing, will likely create sustained demand for precision therapies. As regulatory frameworks evolve to accommodate these advancements, the market will become more accessible, thus enhancing its overall attractiveness to investors and stakeholders.
Recent developments in the Thailand non-oncology precision medicine market indicate a surge in collaborative efforts among healthcare providers, technology companies, and research institutions. Enhanced focus on personalized treatment protocols is becoming evident through the introduction of new digital health applications aimed at facilitating genetic testing and data analysis. There is also a notable increase in public-private partnerships designed to support the integration of precision medicine technologies into standard healthcare practices, further solidifying Thailand's position in the global precision medicine arena.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Non-Oncology Precision Medicine Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, 2022 & 2032F |
3.3 Thailand Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 Thailand Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 Thailand Non-Oncology Precision Medicine Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.6 Thailand Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2022 & 2032F |
4 Thailand Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of precision medicine approaches in healthcare in Thailand |
4.2.2 Growing awareness about personalized treatment options among patients and healthcare providers |
4.2.3 Government initiatives and funding to support precision medicine research and implementation in non-oncology fields |
4.3 Market Restraints |
4.3.1 High costs associated with precision medicine diagnostics and treatments |
4.3.2 Limited availability and accessibility of advanced precision medicine technologies in Thailand |
4.3.3 Regulatory challenges and approvals for precision medicine therapies in non-oncology applications |
5 Thailand Non-Oncology Precision Medicine Market Trends |
6 Thailand Non-Oncology Precision Medicine Market, By Types |
6.1 Thailand Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2022-2032F |
6.1.3 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2022-2032F |
6.1.4 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2022-2032F |
6.1.5 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2022-2032F |
6.1.6 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2022-2032F |
6.1.7 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2022-2032F |
6.2 Thailand Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2022-2032F |
6.2.3 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2022-2032F |
6.2.4 Thailand Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2022-2032F |
7 Thailand Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 Thailand Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 Thailand Non-Oncology Precision Medicine Market Imports from Major Countries |
8 Thailand Non-Oncology Precision Medicine Market Key Performance Indicators |
8.1 Number of clinical trials focusing on non-oncology precision medicine in Thailand |
8.2 Adoption rate of precision medicine tools and technologies in non-oncology specialties |
8.3 Patient outcomes and improvement in treatment efficacy with the use of precision medicine techniques |
9 Thailand Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 Thailand Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2022 & 2032F |
9.2 Thailand Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2022 & 2032F |
10 Thailand Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 Thailand Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2025 |
10.2 Thailand Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here